AUTOLUS THERAPEUTICS PLC - AMERICAN DEPOSITARY SHA

Autolus Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call on March 7, 2023

15 Feb 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics announces Board changes

20 Jan 2023 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Announces Collaboration with Cabaletta Bio for Use of Autolus’ Safety Switch System in Cell Therapies for Autoimmune Disease

09 Jan 2023 07:00:02 By Nasdaq GlobeNewswire

Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs

21 Dec 2022 16:01:00 By Nasdaq GlobeNewswire

Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022

12 Dec 2022 10:00:00 By Nasdaq GlobeNewswire

Autolus Announces Pricing of Public Offering

08 Dec 2022 21:11:25 By Nasdaq GlobeNewswire

Autolus Announces Proposed Public Offering in the United States

08 Dec 2022 16:03:13 By Nasdaq GlobeNewswire

Autolus Therapeutics to Receive $70 Million in Milestone Payments from Blackstone Life Sciences

08 Dec 2022 16:02:48 By Nasdaq GlobeNewswire

Autolus Therapeutics announces pivotal Phase 2 FELIX clinical trial has met primary endpoint at interim analysis

08 Dec 2022 16:01:35 By Nasdaq GlobeNewswire

Autolus Therapeutics announces handover of first clean rooms of new Stevenage, UK, manufacturing facility

30 Nov 2022 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics to Present Three Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2022

03 Nov 2022 09:31:08 By Nasdaq GlobeNewswire

Autolus Therapeutics Reports Third Quarter 2022 Financial Results and Operational Progress

03 Nov 2022 07:00:02 By Nasdaq GlobeNewswire

Autolus Therapeutics to Report Third Quarter 2022 Financial Results on November 3, 2022

21 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Moderna exercises option to license proprietary targeting technology from Autolus

12 Oct 2022 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Announces Collaboration with Bristol Myers Squibb for Use of Autolus’ Proprietary Safety Switch System

04 Oct 2022 07:00:01 By Nasdaq GlobeNewswire

Autolus Therapeutics Reports Second Quarter 2022 Financial Results and Operational Progress

04 Aug 2022 07:00:02 By Nasdaq GlobeNewswire

Correction - Autolus Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022

21 Jul 2022 07:54:01 By Nasdaq GlobeNewswire

Autolus Therapeutics to Report Second Quarter 2022 Financial Results on August 4, 2022

21 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics to Participate in William Blair’s Biotech Focus Conference 2022, New York, July 12 – 13, 2022

06 Jul 2022 07:00:00 By Nasdaq GlobeNewswire

Autolus Therapeutics Presents Clinical Data Updates at the European Hematology Association Congress

10 Jun 2022 03:01:00 By Nasdaq GlobeNewswire